Physician profile
Vedant Vaksha
NPI 1760762033
$10,616.92
in general payments reported to CMS, 2019-2025
20 companies · $329 in 2025
The $329 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,692 · 2020: $188 · 2021: $757 · 2022: $291 · 2023: $347 · 2024: $7,013 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,500 · Food and Beverage: $1,414 · Travel and Lodging: $774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,500.00 |
| Food and Beverage | $1,414.27 |
| Travel and Lodging | $774.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $6,427.56 | 2024-2025 | Maci |
| Stryker Corporation | $1,683.62 | 2019-2024 | Iconix |
| Depuy Synthes Sales INC. | $1,234.32 | 2019-2025 | Fibergraft Bg Morsels, Vivigen Mis Delivery System, Conduit |
| Medtronic USA, INC. | $251.50 | 2019 | |
| Boston Scientific Corporation | $146.56 | 2020-2021 | |
| Smith+Nephew, INC. | $133.67 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2019 | |
| Abbott Laboratories | $114.75 | 2019-2020 | |
| Medtronic, INC. | $86.91 | 2022 | |
| Orthofix Medical, INC. | $82.42 | 2019-2022 | |
| Globus Medical, INC. | $61.04 | 2024 | Xlif |
| Djo, LLC | $48.58 | 2020 | |
| Horizon Therapeutics Plc | $41.16 | 2021-2022 | |
| Si-Bone, INC. | $38.50 | 2019 | |
| Pacira Therapeutics, INC. | $34.21 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Providence Medical Technology, INC. | $33.47 | 2024 | |
| Zimmer Biomet Holdings, INC. | $30.91 | 2025 | Oxford |
| Merck Sharp & Dohme LLC | $18.43 | 2023 | Bridion |
| Zimvie INC. | $12.78 | 2023 | |
| Dynasplint Systems INC. | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vedant Vaksha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.